Imaging biomarkers play a crucial role in the development, approval, and use of disease-modifying drugs for Alzheimer’s disease
Biomarkers, including imaging biomarkers, will be important for managing patients with Alzheimer's disease on disease-modifying drugs (DMD), such as Aduhelm and Leqembi, across the patient pathway.
